GET DAILY SIGNALSBrown & Brown (BRO) Climbs +20% in 30 Days on Sector Momentum and Dividend Hike
Key Takeaways
- Brown & Brown (BRO) climbed roughly 20% over the trailing 30 days, from a close of $60.82 on September 25 to $72.97 on October 23.
- The rebound followed a late-September low near $60 and was driven by strength across insurance-brokerage peers plus a wave of positive analyst actions.
- A 9% dividend increase — the company's 33rd consecutive annual increase — reinforced investor confidence in late October.
- The move builds ahead of third-quarter 2026 results, scheduled for release after the market close on October 26.
- Over the trailing quarter, the stock traced a sharp V-shaped recovery after a late-summer pullback.
- For additional detail, explore Brown & Brown's Price Targets, Earnings, and Forecast pages.
- Explore Trending AI Robots to see how AI-driven trading strategies approach tickers like BRO.
Brown & Brown (BRO): A Leading Insurance Brokerage
Brown & Brown, Inc. (BRO) is one of the largest independent insurance brokerages in the United States. Founded in 1939 and headquartered in Daytona Beach, Florida, the company markets and services property and casualty insurance, employee benefits, and related risk-management products through a network spanning more than 700 locations and roughly 23,000 professionals. Its operations are organized across four segments — Retail, National Programs, Wholesale Brokerage, and Services — with the majority of revenue generated in the United States and additional exposure in the United Kingdom.
As an insurance intermediary, Brown & Brown earns commissions and fees by placing coverage for commercial, professional, and individual customers rather than underwriting risk itself. Investors follow the stock for its diversified revenue base, a long track record of acquisition-driven growth, and a reputation for disciplined expense management. Its scale and specialization position it alongside major brokers such as Marsh & McLennan (MMC) and Aon (AON) in the broader insurance-brokerage sector. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Recent Stock Performance: 30-Day Surge vs. Quarterly Volatility
Over the trailing 30 days, BRO delivered a pronounced rebound. After closing at $60.82 on September 25, shares rallied to $72.97 by October 23, a gain of roughly 20%. The recovery accelerated in the second half of October, with the stock posting several consecutive higher closes and reclaiming levels not seen since early September.
The quarterly picture is more volatile. Following its late-July earnings report, the stock spiked into the mid-$70s before drifting lower through August and September, bottoming near $60 in late September. The subsequent October rally has largely reversed that pullback, leaving shares modestly higher versus three months earlier but on a notably choppy, V-shaped path.
Key Drivers Behind the Recent 30-Day Rally
Several factors combined to fuel the recent advance. Sector momentum was a key catalyst: strong third-quarter results from peer Marsh & McLennan (MMC) in mid-October, along with upbeat news from Aon (AON), lifted sentiment across the insurance-brokerage group and pulled BRO higher in sympathy.
Analyst activity also played a role. In mid-October, KBW upgraded the stock to Outperform, and TD Cowen initiated coverage with a Buy rating, while JPMorgan raised its price target to $83 and Citizens JMP maintained a Buy rating. The moves were not uniformly bullish — Morgan Stanley kept a Sell rating with a $55 target, and Wells Fargo, RBC Capital, Barclays, and Mizuho held more cautious positions — but the net tone around the sector turned more constructive.
Company-specific news provided additional support. On October 21, Brown & Brown declared a quarterly dividend of $0.18 per share, a 9% increase and the company's 33rd consecutive annual dividend increase, signaling continued confidence in cash generation. Improving economic data, including a five-year high in the S&P Global Composite PMI, added a supportive macro backdrop, while anticipation of third-quarter earnings contributed to the upward momentum. From what I see, the combination of peer strength and the dividend news created a constructive setup.
Quarterly Performance: Recovery from Summer Weakness
The broader quarterly narrative reflects a recovery from an earlier bout of weakness. In late July, the company reported second-quarter 2026 revenue of approximately $1.68 billion, up 30.4% year over year, with adjusted earnings per share of $1.07 that narrowly missed the consensus estimate. Shares rose about 5.7% the following day as investors focused on the strong top-line growth and acquisition momentum.
Through August and September, however, the stock gave back much of that gain. Concerns about slowing insurance rate increases in certain coverage lines, moderating organic growth, and rising operating expenses weighed on sentiment and pushed shares toward their late-September low. The October rebound was driven less by company-specific fundamentals than by renewed sector enthusiasm, favorable analyst revisions, and the dividend increase, restoring investor confidence ahead of the next earnings report. I’m watching this closely as the pattern highlights how sector flows can override near-term noise.
Looking Ahead: Earnings and Key Catalysts
Looking ahead, the most immediate catalyst is Brown & Brown's third-quarter 2026 earnings report, due after the market close on October 26. Analysts expect earnings of roughly $1.09 per share on revenue near $1.76 billion, implying high-single-digit top-line growth. The company's guidance and commentary on the insurance rate environment will be closely watched, given that slowing rate increases in certain lines could moderate organic growth.
Other factors to monitor include the pace and integration of acquisitions, net investment income from the proceeds of the company's recent follow-on common stock offering, and expense trends tied to compensation and amortization. Broader macro conditions — interest rates, economic growth, and commercial insurance pricing — remain relevant, as does any further shift in sector-level sentiment following results from larger peers. The analyst consensus currently reflects a Hold-to-Moderate Buy stance with an average price target in the mid-$70s.
Using Tickeron’s AI Tools for Deeper Insight
In preparing this review, I turned to Tickeron’s Trending AI Robots to examine how various automated strategies have handled names like BRO recently. The page highlights a focused selection of top-performing bots from a much larger set, allowing me to compare different approaches and timeframes without sifting through hundreds of options. It provides a practical way to cross-check traditional analysis with algorithmic perspectives.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Momentum Indicator for BRO turns positive, indicating new upward trend
BRO saw its Momentum Indicator move above the 0 level on October 07, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned positive. In 47 of the 80 cases, the stock moved higher in the following days. The odds of a move higher are at 59%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for BRO just turned positive on October 07, 2026. Looking at past instances where BRO's MACD turned positive, the stock continued to rise in 21 of 43 cases over the following month. The odds of a continued upward trend are 49%.
BRO moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BRO crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.
Following a +7.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where BRO advanced for three days, in 174 of 327 cases, the price rose further within the following month. The odds of a continued upward trend are 53%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
BRO broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BRO entered a downward trend on October 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. BRO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 66 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 71 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 82 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock better than average.
The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.940) is normal, around the industry mean (2.661). P/E Ratio (20.440) is within average values for comparable stocks, (18.230). Projected Growth (PEG Ratio) (0.910) is also within normal values, averaging (8.322). Dividend Yield (0.009) settles around the average of (0.045) among similar stocks. P/S Ratio (3.322) is also within normal values, averaging (2.968).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of insurance brokerage services and casualty insurance underwriting services
Industry InsuranceBrokersServices
Advertisement